Abstract
This conference abstract was published in the Proceedings of the American Academy of Neurology Annual Meeting.
| Original language | American English |
|---|---|
| Title of host publication | Proceedings of the American Academy of Neurology Annual Meeting |
| State | Published - Apr 13 2011 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Disciplines
- Epidemiology
- Public Health
Keywords
- Chantix®
- Double-blind
- Friedreich's Ataxia
- Pilot study
- Placebo-controlled
- Randomized
- Treatment
- Varenicline
Fingerprint
Dive into the research topics of 'Double-Blind, Randomized, Placebo-Controlled Pilot Study of Varenicline (Chantix®) in the Treatment of Friedreich’s Ataxia'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver